Mizuho Securities analyst Vijay Rakesh maintained a Hold rating on Qorvo (QRVO – Research Report) today and set a price target of $85.00. The ...
Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback